| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/HEP.30880 |
| P698 | PubMed publication ID | 31344280 |
| P50 | author | Romil Saxena | Q89703970 |
| Pietro Invernizzi | Q37842572 | ||
| Heather L. Francis | Q89701375 | ||
| P2093 | author name string | Nan Wu | |
| Suthat Liangpunsakul | |||
| Chaodong Wu | |||
| Luca Fabris | |||
| Fanyin Meng | |||
| Gianfranco Alpini | |||
| Konstantina Kyritsi | |||
| Tianhao Zhou | |||
| Anatoliy A Gashev | |||
| Travis W Hein | |||
| Julie Venter | |||
| Shannon S Glaser | |||
| Lixian Chen | |||
| Nicholas J Skill | |||
| April O'Brien | |||
| David Zawieja | |||
| Ludovica Ceci | |||
| P2860 | cites work | Serotonin synthesis, release and reuptake in terminals: a mathematical model | Q21245218 |
| 5-HT2B receptor antagonists inhibit fibrosis and protect from RV heart failure | Q21284504 | ||
| Monoamine oxidase A expression is suppressed in human cholangiocarcinoma via coordinated epigenetic and IL-6-driven events | Q28273377 | ||
| Platelet-derived serotonin mediates liver regeneration | Q28306257 | ||
| A role for serotonin (5-HT) in hepatic stellate cell function and liver fibrosis | Q28569215 | ||
| Increased 5-HT2C receptor binding in the brain stem and cerebral cortex during liver regeneration and hepatic neoplasia in rats | Q28573092 | ||
| Regulation of cholangiocyte bicarbonate secretion | Q34344156 | ||
| Paracrine modulation of cholangiocyte serotonin synthesis orchestrates biliary remodeling in adults. | Q34597703 | ||
| Systemic inflammation alters central 5-HT function as determined by pharmacological MRI | Q34615371 | ||
| Knockout of secretin receptor reduces large cholangiocyte hyperplasia in mice with extrahepatic cholestasis induced by bile duct ligation | Q34628746 | ||
| Biogenic amines serotonin and dopamine regulate cholangiocyte hyperplastic and neoplastic growth | Q34992316 | ||
| Effect of 5-HT7 receptor blockade on liver regeneration after 60-70% partial hepatectomy. | Q35460340 | ||
| Progress in monoamine oxidase (MAO) research in relation to genetic engineering | Q35617388 | ||
| Inhibition of histidine decarboxylase ablates the autocrine tumorigenic effects of histamine in human cholangiocarcinoma | Q35629462 | ||
| Multiple signal transduction pathways mediated by 5-HT receptors | Q35700606 | ||
| Biliary physiology in rats with bile ductular cell hyperplasia. Evidence for a secretory function of proliferated bile ductules | Q35810064 | ||
| The Cholangiopathies | Q35942610 | ||
| Life without peripheral serotonin: insights from tryptophan hydroxylase 1 knockout mice reveal the existence of paracrine/autocrine serotonergic networks. | Q36540919 | ||
| Proliferating cholangiocytes: a neuroendocrine compartment in the diseased liver | Q36714754 | ||
| Serotonin metabolism is dysregulated in cholangiocarcinoma, which has implications for tumor growth | Q36996185 | ||
| A human and animal model-based approach to investigating the anti-inflammatory profile and potential of the 5-HT2B receptor antagonist AM1030. | Q37031192 | ||
| The function of serotonin within the liver | Q37086437 | ||
| Dual farnesoid X receptor/TGR5 agonist INT-767 reduces liver injury in the Mdr2-/- (Abcb4-/-) mouse cholangiopathy model by promoting biliary HCO⁻₃ output | Q37096585 | ||
| Serotonin receptor type 3 antagonists improve obesity-associated fatty liver disease in mice | Q38332057 | ||
| Liver 5-HT7 receptors: A novel regulator target of fibrosis and inflammation-induced chronic liver injury in vivo and in vitro | Q38723269 | ||
| The secretin/secretin receptor axis modulates liver fibrosis through changes in transforming growth factor-β1 biliary secretion in mice | Q38775284 | ||
| 5-HT2A receptor antagonists inhibit hepatic stellate cell activation and facilitate apoptosis | Q39202142 | ||
| Secretin stimulates biliary cell proliferation by regulating expression of microRNA 125b and microRNA let7a in mice. | Q39979273 | ||
| E2F1 is a novel fibrogenic gene that regulates cholestatic liver fibrosis through the Egr-1/SHP/EID1 network | Q42289050 | ||
| Serotonin deficiency exacerbates acetaminophen-induced liver toxicity in mice | Q43122702 | ||
| Autocrine/paracrine regulation of the growth of the biliary tree by the neuroendocrine hormone serotonin. | Q45212253 | ||
| Different properties of the central and peripheral forms of human tryptophan hydroxylase | Q45233007 | ||
| The effect of terguride in carbon tetrachloride-induced liver fibrosis in rat. | Q46429020 | ||
| Modulation of bleomycin-induced lung fibrosis by serotonin receptor antagonists in mice. | Q46717257 | ||
| Prolonged darkness reduces liver fibrosis in a mouse model of primary sclerosing cholangitis by miR-200b down-regulation. | Q47850237 | ||
| Monoamine oxidase A imaging in peripheral organs in healthy human subjects | Q48296064 | ||
| Serotonin mediates oxidative stress and mitochondrial toxicity in a murine model of nonalcoholic steatohepatitis. | Q55044281 | ||
| Ductular reaction in liver diseases: pathological mechanisms and translational significances | Q57112577 | ||
| Treatment of pruritus in chronic liver disease with the 5-hydroxytryptamine receptor type 3 antagonist ondansetron: a randomized, placebo-controlled, double-blind cross-over trial | Q77609350 | ||
| Serotonin skews human macrophage polarization through HTR2B and HTR7 | Q85969067 | ||
| Ketanserin, a serotonin 2A receptor antagonist, alleviates ischemia-related biliary fibrosis following donation after cardiac death liver transplantation in rats | Q87419222 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 990-1008 | |
| P577 | publication date | 2019-10-18 | |
| P1433 | published in | Hepatology | Q15724398 |
| P1476 | title | Modulation of the Tryptophan Hydroxylase 1/Monoamine Oxidase-A/5-Hydroxytryptamine/5-Hydroxytryptamine Receptor 2A/2B/2C Axis Regulates Biliary Proliferation and Liver Fibrosis During Cholestasis | |
| P478 | volume | 71 |
| Q89701954 | Biliary damage and liver fibrosis are ameliorated in a novel mouse model lacking l-histidine decarboxylase/histamine signaling |
| Q89797164 | Cholangiocarcinoma: novel therapeutic targets |
| Q90110648 | Histamine-2 Receptor Vivo-Morpholino Treatment Ameliorates Large Bile Duct Damage in Mice Deficient in ATP Binding Cassette Subfamily B Member 4 (Abcb4-/-) via Down-Regulation of cAMP/ERK Signaling |
| Q89761775 | Neuroendocrine Changes in Cholangiocarcinoma Growth |
Search more.